Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2025-12-24 @ 10:41 PM
NCT ID:
NCT06567535
Eligibility Criteria:
Inclusion Criteria:
1. They are between 18 and 75 years old
2. Imaging and puncture pathology showed odontogenic cystic lesion of the mandible
3. Cystic lesions greater than or equal to 2cm in diameter and spread to the inferior alveolar nerve
4. New or recurrent cyst lesions, or odontogenic cystic lesions that are still greater than or equal to 2cm after other treatment such as fenestration and affecting the lower alveolar nerve
5. No serious systemic disease, tolerant of general anesthesia
6. Patients undergoing surgical treatment for mandibular bone cysts under general anesthesia
7. There was no inferior alveolar nerve injury before operation
8. Have not participated in other clinical trials within 30 days
9. Patients who volunteer to participate in the program and sign informed consent
Exclusion Criteria:
1. The patient has severe systemic disease or pregnancy, and is judged to be unable to tolerate the course of this clinical study and cannot tolerate general anesthesia after evaluation by the research team and multidisciplinary consultation
2. Inability to complete the entire clinical research process due to personal, social, and economic reasons
3. Patients with psychiatric disorders or inability to perceive and communicate normally, such as schizophrenia, claustrophobia, etc., are unable to complete the examination and cooperate in the entire clinical research process
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06567535
Study Brief:
Protocol Section:
NCT06567535